Skip to content
value.today

Endlyz Therapeutics, Inc.

🇺🇸 Boston, Massachusetts, USABiotechnologyFounded 2021
Total raised
$21 M
2 rounds on record
Latest round
$17 M
Mar 2026
First round on record
Jul 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Endlyz Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2026$17 MNo. 2$10 to $50 million

Endlyz Therapeutics, Inc.: Raise no. 2, Mar 2026

Investors in this round

7 investors had bought by the notice of May 7, 2026: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $20 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joanna Wolak · Executive Officer, Director
  • Donmienne Leung · Director
  • Justian Craig Fox · Director
  • Laurence Barker · Director
  • Timothy Edwards · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount and Total Amount Sold each includes the conversion of outsanding convertible securities.”

Signed by Joanna Wolak, Chief Executive Officer. Newest notice filed May 7, 2026. Read the notice at the SEC.

equitySEC
Jul 2021$3 MNo. 1$2 to $10 million

Endlyz Therapeutics, Inc.: Raise no. 1, Jul 2021

Investors in this round

6 investors had bought by the notice of Jul 29, 2021: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $7 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joanna Wolak · Executive Officer
  • Zaven Kaprielian · Executive Officer, Director
  • Damian Crowther · Director
  • John Gustofson · Director
  • Jonathan Behr · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Zaven Kaprielian, President. Newest notice filed Jul 29, 2021. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Endlyz Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2026).

    SEC Form D · May 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Endlyz Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Endlyz Therapeutics, Inc.
NameRoleNamed in
Joanna WolakExecutive officerMay 2026
Zaven KaprielianExecutive officerJul 2021
Donmienne LeungDirectorMay 2026
Joanna WolakDirectorMay 2026
Justian Craig FoxDirectorMay 2026
Laurence BarkerDirectorMay 2026
Timothy EdwardsDirectorMay 2026
Damian CrowtherDirectorJul 2021
John GustofsonDirectorJul 2021
Jonathan BehrDirectorJul 2021
Zaven KaprielianDirectorJul 2021